Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Internal analgesic warning label size would be reduced by 40% under NDMA proposal.

This article was originally published in The Tan Sheet

Executive Summary

OTC INTERNAL ANALGESICS WARNING SIZE WOULD BE REDUCED BY 40%, from 52 to 30 words, under a proposal presented to FDA by the Non-prescription Drug Manufacturers Association at an Aug. 17 "OTC feedback" meeting on label reform. The meeting was the first in a series between FDA and NDMA that will focus on OTC labeling issues.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084209

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel